ENCORE: A randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients on enzyme replacement therapy who have reached therapeutic goals.
Saved in:
| Title: | ENCORE: A randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients on enzyme replacement therapy who have reached therapeutic goals. |
|---|---|
| Authors: | Cox, Timothy M.1, Drelichman, Guillermo2, Cravo, Renata3, Balwani, Manisha4, Burrow, Thomas Andrew5, Martins, Ana Maria6, Lukina, Elena7, Rosenbloom, Barry8, Ross, Leorah9, Angell, Jennifer9, Puga, Ana Cristina9 |
| Source: | Molecular Genetics & Metabolism. Feb2014, Vol. 111 Issue 2, pS33-S33. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
